James A. Ross

11.0k total citations
217 papers, 8.3k citations indexed

About

James A. Ross is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, James A. Ross has authored 217 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 45 papers in Physiology and 36 papers in Surgery. Recurrent topics in James A. Ross's work include Nutrition and Health in Aging (35 papers), Liver physiology and pathology (14 papers) and Pluripotent Stem Cells Research (13 papers). James A. Ross is often cited by papers focused on Nutrition and Health in Aging (35 papers), Liver physiology and pathology (14 papers) and Pluripotent Stem Cells Research (13 papers). James A. Ross collaborates with scholars based in United Kingdom, United States and Australia. James A. Ross's co-authors include Kenneth C.H. Fearon, Kenneth C. H. Fearon, Stephen J. Wigmore, J. Falconer, David C. Carter, Jianliang Xiao, O. James Garden, David C. Hay, James R. Black and Tom Preston and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

James A. Ross

203 papers receiving 8.0k citations

Peers

Countries citing papers authored by James A. Ross

Since Specialization

Citations

This map shows the geographic impact of James A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Ross more than expected).

Fields of papers citing papers by James A. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Ross. The network helps show where James A. Ross may publish in the future.

Co-authorship network of co-authors of James A. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Ross. A scholar is included among the top collaborators of James A. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Ross. James A. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The markets in crypto assets regulation: What should firms be doing now? 2024 ·James A. Ross, (unknown)	0
2	Estimating kinetic energy reduction for terminal ballistics using a hyperparameter-optimized neural network 2024 ·Neural Computing and Applications ·(unknown), (unknown), James A. Ross, Yi Zhang	1
3	Oxidative stress and docosahexaenoic acid injury lead to increased necroptosis and ferroptosis in retinal pigment epithelium 2023 ·Scientific Reports ·(unknown), (unknown), Kevin Gallagher, James A. Ross	14
4	BEV-SLAM: Building a Globally-Consistent World Map Using Monocular Vision 2022 ·2022 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) ·James A. Ross, (unknown), (unknown), (unknown), Richard Bowden	9
5	The influence of hypoxia on the prostate cancer proteome 2020 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·James A. Ross, Johannes P.C. Vissers, Jyoti Nanda, Grant D. Stewart, Holger Husi, Fouad K. Habib, Dean E. Hammond, Lee A. Gethings	13
6	INVESTIGATING THE USE OF SAMPLE ENTROPY TO DETECT FATIGUE 2017 ·ISBS Proceedings Archive ·Paul Taylor, James A. Ross, Justin Keogh	1
7	Recent early clinical drug development for acute kidney injury 2016 ·Expert Opinion on Investigational Drugs ·Kevin Gallagher, Stephen O’Neill, Ewen M. Harrison, James A. Ross, Stephen J. Wigmore, Jeremy Hughes	24
8	The Human Urinary Proteome Fingerprint Database UPdb 2013 ·PubMed ·Holger Husi, (unknown), Richard J.E. Skipworth, Nathan Stephens, Carolyn Greig, Henning Wackerhage, Rona Barron, Kenneth C. H. Fearon, James A. Ross	10
9	Suppression of Skeletal Muscle Turnover in Cancer Cachexia: Evidence from the Transcriptome in Sequential Human Muscle Biopsies 2012 ·Clinical Cancer Research ·Iain J. Gallagher, Nathan Stephens, Alisdair J. MacDonald, Richard J. E. Skipworth, Holger Husi, Carolyn Greig, James A. Ross, James A. Timmons, Kenneth C.H. Fearon	70
10	OVERVIEW OF HAZARD ASSESSMENT AND EMERGENCY PLANNING SOFTWARE OF USE TO RN FIRST RESPONDERS 2009 ·Health Physics ·Edward Waller, (unknown), William F. Blakely, James A. Ross, (unknown), David J. Sandgren, (unknown), (unknown), Jeffrey Nemhauser, John S. Nasstrom, G Sugiyama, (unknown), Brooke Buddemeier, (unknown), (unknown)	12
11	A SIMPLE POLYURETHANE MATRIX PROMOTES HEPATIC ENDODERM VIABILITY AND INDUCIBLE DRUG METABOLISM: IMPLICATIONS FOR DRUG TOXICOLOGY TESTING AND THE DESIGN OF LIVER SUPPORT DEVICES 2009 ·Hepatology ·David C. Hay, Salvatore Pernagallo, Juan J. Díaz‐Mochón, J. Schrader, Judy Fletcher, (unknown), Claire N. Medine, James R. Black, Alexandra Thompson, Zara Hannoun, Philip N. Newsome, Stuart J. Forbes, James A. Ross, Mark Bradley, John P. Iredale	1
12	Side population cells in developing human liver are primarily haematopoietic progenitor cells 2009 ·Experimental Cell Research ·John Terrace, David C. Hay, Kay Samuel, Catherine Payne, Richard A. Anderson, Ian Currie, Rowan W. Parks, Stuart J. Forbes, James A. Ross	13
13	The Inhibitory Role of Stromal Cell Mesenchyme on Human Embryonic Stem Cell Hepatocyte Differentiation is Overcome by Wnt3a Treatment 2008 ·Cloning and Stem Cells ·Judy Fletcher, Wei Cui, Kay Samuel, James R. Black, Zara Hannoun, Ian Currie, John Terrace, Catherine Payne, Céline Filippi, Philip N. Newsome, Stuart J. Forbes, James A. Ross, John P. Iredale, David C. Hay	19
14	The effects of macrophage migratory inhibitory factor on acute-phase protein production in primary human hepatocytes 2006 ·International Journal of Molecular Medicine ·Nick Wheelhouse, Nabil Dowidar, Cornelis H.C. Dejong, O. James Garden, James J. Powell, Matthew D. Barber, Kathryn Sangster, Jean Maingay, James A. Ross	11
15	Mental Health in F-111 Maintenance Workers: The Study of Health Outcomes in Aircraft Maintenance Personnel (SHOAMP) General Health and Medical Study 2006 ·Journal of Occupational and Environmental Medicine ·John Attia, (unknown), Peter W. Schofield, Anthony M. Brown, Richard Gibson, Meredith Tavener, (unknown), Warren Harrex, James A. Ross	12
16	Impact of early endovascular aneurysmal occlusion on outcome of patients in poor grade after subarachnoid haemorrhage 2002 ·Journal of Clinical Neuroscience ·James A. Ross, Maureen J. O’Sullivan, I. S. Grant, Robin Sellar, Ian R. Whittle	1
17	Elevated levels of soluble tumor necrosis factor receptors are associated with increased mortality rates in patients who undergo operation for ruptured abdominal aortic aneurysm 2000 ·Journal of Vascular Surgery ·Donald J. Adam, Amanda Lee, C V Ruckley, Andrew W. Bradbury, James A. Ross	4
18	The anti-catabolic effects of n-3 fatty acids 1999 ·Current Opinion in Clinical Nutrition & Metabolic Care ·James A. Ross, Alastair G.W. Moses, Kenneth C.H. Fearon	42
19	VARIATIONS IN THE RENAL VASCULAR PEDICLE: (An Anatomical and Radiological Study with Particular Reference to Renal Transplantation)1 1961 ·British Journal of Urology ·James A. Ross, Eric Samuel, (unknown)	42
20	CONGENITAL RECTO‐URINARY FISTULA 1951 ·British Journal of Urology ·Robert Stewart, James A. Ross	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact